371 Results for: created: (01/2018 to 01/2018)

People

  1. Adusumilli
    Adusumilli
  2. Eguchi
    Eguchi
  3. Jones
    Jones
  4. Travis
    Travis
  5. Lu
    Lu
  6. Wu
    Wu
  7. Damato
    Damato
  8. Motzer
    Motzer
  9. Rimner
    Rimner
  10. Taggar
    Taggar

Groups

  1. Department of Medicine (148)
  2. Solid Tumor Oncology Division (96)
  3. Sloan Kettering Institute Postdocs (87)
  4. Surgery (81)
  5. GSK Faculty (76)
  6. Center for Hematologic Malignancies (50)
  7. Epidemiology and Biostatistics (48)
  8. Survivorship Research (48)
  9. Hematologic Malignancies, Division of (47)
  10. Department of Pathology and Laboratory Medicine (43)
  1. "2017"
Formats
  1. Journal Article (239)
  2. Meeting Abstract (118)
  3. Book Section (13)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (148)
  2. Solid Tumor Oncology Division (96)
  3. Sloan Kettering Institute Postdocs (87)
  4. Surgery (81)
  5. GSK Faculty (76)
  6. Center for Hematologic Malignancies (50)

More Groups

People
  1. Prasad Adusumilli (27)
  2. David Jones (19)
  3. Takashi Eguchi (19)
  4. William Travis (15)
  5. Abraham Wu (11)
  6. Shaohua Lu (11)

More People

Years
  1. 2017 (371)
Publications
  1. Journal of Thoracic Oncology (53)
  2. Neuro-Oncology (27)
  3. Clinical Cancer Research (11)
  4. Journal of Clinical Oncology (11)
  5. Brachytherapy (10)
  6. Leukemia Research (8)

More Publications

Publishers
  1. Elsevier Inc. (79)
  2. Oxford University Press (34)
  3. Elsevier Science, Inc. (29)
  4. Springer (19)
  5. American Association for Cancer Research (18)
  6. Wiley Blackwell (13)

More Publishers

Results (371)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic subtype of early-stage lung adenocarcinoma is a predictor of failure patterns after stereotactic body radiation therapy
    Meeting Abstract

    Leeman, J.; Rimner, A.; Montecalvo, J.; Hsu, M.; Zhang, Z.; Von Reibnitz, D.; Panchoo, K.; Yorke, E.; Adusumilli, P.; Travis, W.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • In early-stage lung adenocarcinomas, survival by tumor size (T) is further stratified by tumor spread through air spaces
    Meeting Abstract

    Eguchi, T.; Kameda, K.; Lu, S.; Bott, M.; Tan, K. S.; Jones, D.; Travis, W.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Early life dietary pattern and risk of monoclonal gammopathy of undetermined significance
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E. K.; Birgisdottir, B. E.; Steingrimsdottir, L.; Eiriksdottir, G.; Harris, T. B.; Landgren, O.; Gudnason, V.; Torfadottir, J. E.; Kristinsson, S. Y.
    European Journal of Public Health (2017)

    Fulltext@MSK | Save
  • Impact of increasing age on cause specific mortality and morbidity in stage I NSCLC patients: A competing risk analysis
    Meeting Abstract

    Eguchi, T.; Bains, S.; Tan, K. S.; Bains, M.; Downey, R.; Huang, J.; Isbell, J.; Park, B.; Rusch, V.; Jones, D.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Update on the mesothelioma staging system
    Meeting Abstract

    Rusch, V.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • First-line nivolumab monotherapy and nivolumab plus ipilimumab in patients with advanced NSCLC: Long-term outcomes from CheckMate 012
    Meeting Abstract

    Gettinger, S.; Rizvi, N.; Chow, L.; Borghaei, H.; Brahmer, J.; Shepherd, F.; Ready, N.; Gerber, D.; Antonia, S.; Goldman, J. W.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1 selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Garassino, M.; Rizvi, N.; Besse, B.; Jänne, P.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Converting tumor-mediated PD-L1 inhibition into CAR T-cell costimulation to potentiate thoracic cancers immunotherapy
    Meeting Abstract

    Morello, A.; Chen, N.; Cherkassky, L.; Sadelain, M.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Multi-institutional phase 2 trial of high-dose stereotactic body radiation therapy with temporary hydrogel spacer for low- and intermediate-risk prostate cancer
    Meeting Abstract

    Folkert, M. R.; Zelefsky, M. J.; Hannan, R.; Desai, N. B.; Lotan, Y.; Laine, A. M.; Kim, D. W. N.; Hardee, S.; Hornberger, B.; Kollmeier, M. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: A Gynecology Oncology Group study
    Meeting Abstract

    Randall, M.; Filiaci, V.; McMeekin, D.; Yashar, C. M.; Mannel, R.; Salani, R.; DiSilvestro, P.; Burke, J.; Rutherford, T.; Spirtos, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save